Acute vanishing bile duct syndrome after ibuprofen therapy in a child

Journal of Pediatrics

Volumn 145, Issue 2, 2004, Pages 273-276

  Taghian, M ^a   Tran, T A ^a   Bresson Hadni, S ^a   Menget, A ^a   Felix, S ^a   Jacquemin, E ^a,b  

^a Vesoul Hospital   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Nonsteroidal anti inflammatory drugs; NSAIDs; Vanishing bile duct syndrome; VBDS

Indexed keywords

ALANINE AMINOTRANSFERASE; IBUPROFEN; RIFAMPICIN; URSODEOXYCHOLIC ACID;

ANAMNESIS; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT DISEASE; CASE REPORT; CHOLANGITIS; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; HUMAN; IMMUNOASSAY; LABORATORY TEST; PRIORITY JOURNAL; RASH; RHINOPHARYNGITIS; SARCOIDOSIS; SCHOOL CHILD; SCREENING TEST; SEROLOGY; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TREATMENT FAILURE; TREATMENT OUTCOME; VANISHING BILE DUCT SYNDROME;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BILE DUCT DISEASES; BILE DUCTS, INTRAHEPATIC; CHILD; CHOLESTASIS; FEMALE; HUMANS; IBUPROFEN; STEVENS-JOHNSON SYNDROME; SYNDROME;

EID: 3342912298     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.05.027     Document Type: Article

References (19)

1. Degott C., Feldman G., Larrey D., Durand-Schneider A.M., Grange D., Machayekhi J.P., et al. Drug-induced prolonged cholestasis in adults: a histological semi-quantitative study demonstrating progressive ductopenia. Hepatology. 15:1992;244-251
2. Geubel A.P., Sempoux C., Rahier J. Bile duct disorders. Clin Liver Dis. 7:2003;295-309
3. Hadchouel M. Paucity of interlobular bile ducts. Semin Diagn Pathol. 9:1992;24-30
4. Ludwig J. Vanishing bile duct syndrome. Bircher J., Benhamou J.P., McIntyre N.,, et al. Oxford textbook of clinical hepatology. 2nd ed. :1999;1131-1133 Oxford University Press, Oxford
5. Furuya K.N., Roberts E.A., Canny G.J., Phillips M.J. Neonatal hepatitis syndrome with paucity of interlobular bile ducts in cystic fibrosis. J Pediatr Gastroenterol Nutr. 12:1991;127-130
6. Srivastava M., Perez-Atayde A., Jonas M.M. Drug associated acute-onset vanishing bile duct and Stevens-Johnson Syndrome in a child. Gastroenterology. 115:1998;743-746
7. Alam I., Ferrell L.D., Bass N.M. Vanishing bile duct syndrome temporally associated with ibuprofen use. Am J Gastroenterol. 91:1996;1626-1630
8. Chitturi S., Farrell G.C. Drug-induced cholestasis. Semin Gastrointest Dis. 12:2001;113-124
9. Dousset B., Conti F., Houssin D., Calmus Y. Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients. N Engl J Med. 330:1994;1160-1161
10. Stempel D.A., Miller J.J. III. Lymphopenia and hepatic toxicity with ibuprofen. J Pediatr. 90:1997;657-658
11. Boelslerli U.A., Zimmerman H.J., Kretz-Rommel A. Idiosyncratic liver toxicity of non-steroidal anti-inflammatory drugs: molecular mechanisms and pathology. Crit Rev Toxicol. 25:1995;207-235
12. Halpern S.M., Fitzpatrick R., Volans G.N. Ibuprofen toxicity: a review of adverse reactions and overdose. Adverse Drug React Toxicol Rev. 12:1993;107-128
13. Batts K.P., Moore S.B., Perkins J.D., Wiesner R.H., Grambsch P.M., Krom R.A. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation. 45:1988;376-379
14. Fiorucci S., Antonelli E. Cyclo-oxygenase isoenzymes: structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents. Dig Liver Dis. 33:2001;S2-S7
15. Menniti-Ippolito F., Sagliocca L., Da Cas R., Saggiomo G., Di Nardo R., Traversa G., et al. Niflumic acid and cutaneous reactions in children. Arch Dis Child. 84:2001;430-431
16. Morelli M.S., O'Brien F.X. Stevens-Johnson syndrome and cholestatic hepatitis. Dig Dis Sci. 46:2001;2385-2388
17. Paumgartner G., Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 36:2002;525-531
18. O'Brien C.B., Shields D.S., Saul S.H., Reddy K.R. Drug-induced vanishing bile duct syndrome: response to ursodiol. Am J Gastroenterol. 91:1996;1456-1457
19. Cranswick N., Coghlan D. Paracetamol efficacy and safety in children: the first 40 years. Am J Ther. 7:2000;135-141